Mark Wong Selected Research

Drug Therapy (Chemotherapy)

1/2023	Treatment of rectal cancer after previous prostate cancer: A single institution experience.
11/2021	Can adjuvant pelvic radiation therapy after local excision or polypectomy for T1 and T2 rectal cancer offer an alternative option to radical surgery?
8/2019	Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?
10/2017	Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
10/2016	Regorafenib for the Treatment of Advanced Gastric Cancer (INTEGRATE): A Multinational Placebo-Controlled Phase II Trial.
1/2005	Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Wong Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 06/2004
3	Lymphoma (Lymphomas) 04/2022 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 10/2016
2	Adenocarcinoma 01/2023 - 10/2016
2	Rectal Neoplasms (Rectal Cancer) 01/2023 - 11/2021
2	Mycosis Fungoides 04/2022 - 11/2021
2	Breast Neoplasms (Breast Cancer) 08/2019 - 01/2016
2	Hot Flashes 08/2019 - 01/2016
2	Thrombocytopenia (Thrombopenia) 10/2017 - 09/2012
2	Colorectal Neoplasms (Colorectal Cancer) 05/2017 - 01/2017
2	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2005
1	Klatskin Tumor 02/2024
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 04/2022
1	Carcinoma (Carcinomatosis) 11/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Hyperpigmentation 01/2019
1	Coinfection 01/2019
1	Hepatitis 01/2019
1	Hepatitis B 01/2019
1	Immune Reconstitution Inflammatory Syndrome 01/2019
1	Hepatic Encephalopathy 11/2018
1	Peritonitis 11/2018
1	Subacute Combined Degeneration 05/2018
1	Angioedema 01/2018
1	Pulmonary Embolism 10/2017
1	Headache (Headaches) 10/2017
1	Glioblastoma (Glioblastoma Multiforme) 10/2017
1	Fatigue 10/2017
1	Disease Progression 10/2016
1	Ovarian Neoplasms (Ovarian Cancer) 05/2014
1	Hypersplenism (Anemia, Splenic) 09/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2012
1	Liver Diseases (Liver Disease) 09/2012
1	Anemia 09/2012
1	End Stage Liver Disease 09/2012
1	Intracranial Hypertension 08/2008
1	Hypothermia 08/2008

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 04/2023 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 05/2014
2	Leucovorin (Folinic Acid)FDA Link 04/2023 - 01/2023
2	Docetaxel (Taxotere)FDA Link 04/2023 - 01/2023
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2023 - 01/2023
2	4-hydroxy-N-desmethyltamoxifenIBA 08/2019 - 01/2016
2	Tamoxifen FDA LinkGeneric 08/2019 - 01/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2017
2	TTI-621IBA 02/2017 - 01/2017
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 02/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2023
1	Therapeutic UsesIBA 04/2022
1	AntibodiesIBA 04/2022
1	InterferonsIBA 11/2021
1	LigandsIBA 01/2021
1	AntigensIBA 01/2020
1	Hepatitis B e AntigensIBA 01/2019
1	IronIBA 01/2019
1	Rifaximin (L 105)FDA Link 11/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2018
1	icatibantIBA 01/2018
1	epidermal growth factor receptor VIIIIBA 10/2017
1	rindopepimutIBA 10/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2017
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 10/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017
1	RNA (Ribonucleic Acid)IBA 05/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	regorafenibIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2016
1	Adenosine Triphosphate (ATP)IBA 05/2014
1	Hemostatics (Antihemorrhagics)IBA 08/2008
1	Pentobarbital (Nembutal)FDA Link 08/2008
1	Mannitol (Osmitrol)FDA LinkGeneric 08/2008
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2006
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2005
1	Technetium (Technetium 99m)IBA 01/2005
1	Indicators and Reagents (Reagents)IBA 01/2005
1	Cytochrome P-450 CYP3AIBA 06/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2023 - 01/2005
5	Therapeutics 04/2022 - 09/2012
3	Radiotherapy 04/2023 - 11/2021
3	Immunotherapy 04/2022 - 10/2017
2	Neoadjuvant Therapy 01/2023 - 01/2023
1	Proctectomy 11/2021
1	Drug Tapering 08/2019
1	Highly Active Antiretroviral Therapy (HAART) 01/2019
1	Gluten-Free Diet 05/2018
1	Intradermal Injections 10/2017
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 09/2012
1	Decompression 09/2012
1	Stents 09/2012
1	Transjugular Intrahepatic Portasystemic Shunt 09/2012